| 000 | 01605 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250513141529.0 | ||
| 264 | 0 | _c19980501 | |
| 008 | 199805s 0 0 eng d | ||
| 022 | _a0039-2499 | ||
| 024 | 7 |
_a10.1161/01.str.29.4.837 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aVeltkamp, R | |
| 245 | 0 | 0 |
_aPotassium channel activators protect the N-methyl-D-aspartate-induced cerebral vascular dilation after combined hypoxia and ischemia in piglets. _h[electronic resource] |
| 260 |
_bStroke _cApr 1998 |
||
| 300 |
_a837-42; discussion 842-3 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAnalysis of Variance |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aAnimals, Newborn |
| 650 | 0 | 4 |
_aBenzimidazoles _xtherapeutic use |
| 650 | 0 | 4 |
_aCalcitonin Gene-Related Peptide _xpharmacology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHypoxia, Brain _xdrug therapy |
| 650 | 0 | 4 |
_aIschemic Attack, Transient _xdrug therapy |
| 650 | 0 | 4 |
_aKainic Acid _xpharmacology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aN-Methylaspartate _xpharmacology |
| 650 | 0 | 4 |
_aPapaverine _xpharmacology |
| 650 | 0 | 4 |
_aPicolines _xtherapeutic use |
| 650 | 0 | 4 |
_aPotassium Channels _xagonists |
| 650 | 0 | 4 |
_aPyrans _xtherapeutic use |
| 650 | 0 | 4 | _aSwine |
| 650 | 0 | 4 |
_aVasodilator Agents _xpharmacology |
| 700 | 1 | _aDomoki, F | |
| 700 | 1 | _aBari, F | |
| 700 | 1 | _aBusija, D W | |
| 773 | 0 |
_tStroke _gvol. 29 _gno. 4 _gp. 837-42; discussion 842-3 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1161/01.str.29.4.837 _zAvailable from publisher's website |
| 999 |
_c9517942 _d9517942 |
||